Natera, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Natera, Inc. on August 15, 2019. The filing reports a corporate governance event regarding the Board of Directors. Natera is a Delaware corporation with its principal executive offices in San Carlos, California, and its common stock trades on the Nasdaq Global Select Market under the symbol "NTRA."
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on the appointment of a new director and does not contain financial performance data.
Material Changes
The Board of Directors increased the size of the full Board from nine to ten members. Rowan E. Chapman, Ph.D., was appointed as a new member of the Board, effective immediately. Dr. Chapman will serve as a Class II director with an initial term expiring at the 2020 annual meeting of stockholders. No committee assignments were made at the time of this filing.
Guidance, Outlook, and Compensation
Dr. Chapman is entitled to receive cash and equity compensation consistent with the Company's other non-employee directors, as described in the Company's Form 10-Q filed on May 10, 2019. The Company also entered into an Indemnification Agreement with Dr. Chapman. The filing does not contain management commentary on business outlook, risks, or contingencies beyond the standard disclosures regarding the director appointment.
Key Facts for Investor Verification
- Board size increased from nine to ten members.
- Rowan E. Chapman, Ph.D., appointed as a Class II director effective August 15, 2019.
- Director compensation aligns with the existing program for non-employee directors.
- Dr. Chapman has no family relationships with current directors or officers.
- No financial results or operational metrics are disclosed in this specific filing.